Rationale:Myeloid sarcomas (MSs) are rare malignant hematological tumors. They most commonly occur in patients with acute or chronic myeloid leukemia. A de novo MS with no evidence of blood system disease is rare, but may represent the first sign of a systemic illness that precedes a full-blown disease. Herein, we report the computed tomography (CT) findings of an extremely rare case of a nonleukemic MS that progressed to acute myelogenous leukemia (AML) and simultaneously involved the small intestine, kidneys, mesentery, and mesenteric lymph nodes. Moreover, we provide CT findings before and after AML chemotherapy, which have not been reported previously.Patient concerns:A 25-year-old man with intermittent upper abdominal pain for 6 months was admitted to the hospital on November 28, 2015. Initial CT showed concentric wall thickening of the jejunum with an adjacent mesenteric soft tissue mass and mesenteric lymph nodes enlargement. Both kidneys were involved as indicated by the presence of well-defined mildly dilated lesions. During the laparoscopic surgery, the small intestinal tumor, mesenteric soft tissue mass, and mesenteric lymph nodes were removed.Diagnoses:The pathological diagnosis was an MS.Interventions:The patient refused systemic chemotherapy and was rehospitalized with persistently aggravated abdominal distension on February 17, 2016. Follow-up CT showed diffuse small bowel wall thickening, widespread infiltration of the peritoneum, omentum, and mesentery, mesenteric lymph node enlargement, and large amounts of ascites fluid. The lesions in both kidneys were substantially larger and more numerous than on initial CT. Then the patient was treated with conventional AML chemotherapy.Outcomes:The patient achieved complete hematological remission on bone marrow examination. Follow-up CT in September 4, 2016, showed none of the abnormalities seen on initial CT. Currently, the patient is in complete remission.Lessons:If the radiological examination shows lesions at multiple sites, and these lesions are soft tissue masses with homogenous enhancement, MS should be considered in the differential diagnosis, and an aspiration biopsy should be performed to provide a definitive pathological diagnosis. If MS is diagnosed, systemic chemotherapy is crucial to recovery; otherwise, the disease may progress rapidly. Medical imaging is helpful for diagnosing MS and for monitoring treatment response.

Background:The aim of this study was to evaluate the utility of computed tomography (CT) vascular reconstruction in the localization diagnosis of perigastric mass.Methods:Fifty-eight patients with pathologically detected perigastric mass underwent abdominal dynamic contrast-enhanced CT. CT vascular reconstructions were produced from arterial phase data using volume rendering (VR), multiplanar reconstruction (MPR), and maximal intensity projection (MIP). Image analysis was focused on the relationship between the mass, perigastric arteries, and the gastric wall. Localization diagnosis values were compared between CT vascular reconstruction and dynamic-enhanced CT images.Results:Among the 58 cases of perigastric mass, 41 cases originated from the stomach, 7 cases from the left liver lobe, 6 from the pancreas, 2 from lessor omental bursa, 1 from transverse mesocolon, and 1 from left adrenal gland. The accuracy of CT vascular reconstruction images in the localization diagnosis of perigastric mass was higher than that of dynamic-enhanced CT images (98.3% and 86.2%, respectively, P = .04). On the reference level, 35 (35/41) patients with stomach-originated masses showed the mass adjacent perigastric arteries pushed away from the stomach (arterial displacement sign), and 15 (15/17) patients with nonstomach-originated masses showed perigastric arteries between the mass and the stomach (arterial entrapment sign). The sensitivity, specificity, positive predictive value, and negative predictive value of the localization diagnosis of perigastric mass with arterial displacement sign were 85.4%, 100%, 100%, and 73.9%, respectively, and with arterial entrapment sign, 88.2%, 100%, 100%, and 95.3%, respectively.Conclusion:CT vascular reconstruction can clearly depict the relationship between perigastric mass and adjacent perigastric arteries, which may help us more accurately differentiate between stomach-originated and nonstomach-originated masses compared with original dynamic-enhanced CT images.

Background: Magnetic resonance spectroscopy (MRS) of infants with bilirubin encephalopathy shows abnormal changes in the metabolite concentrations in various parts of the brain. Diffusional kurtosis imaging (DKI) is an extension of diffusion tensor imaging (DTI), which includes non-Gaussian diffusion effects, thereby allowing more comprehensive characterization of microstructural changes in pathological analysis. Objectives:Our study retrospectively analyzed DKI data to determine whether the DKI profiles of newborns with bilirubin encephalopathy can evaluate microstructural changes and illustrate related mechanisms. This study also verified whether DKI parametrics can serve as an in vivo marker for neonatal bilirubin encephalopathy. Patients and Methods:A total of 17 patients with neonatal bilirubin encephalopathy and 21 healthy, age-matched control newborns were included in this study. Conventional MRI and DKI were performed for all patients and controls. The mean kurtosis (MK), axial kurtosis (AK), radial kurtosis (RK), fractional anisotropy (FA), and mean diffusion (MD) were obtained from the voxels of interest (VOIs) within the bilateral globus pallidus, putamen, and thalamus. Results:Compared with the control group, the MK, AK, RK, and FA in all VOIs were significantly decreased in neonatal bilirubin encephalopathy, whereas MD increased. Among the kurtosis tensor parameters, RK had the largest change between groups (reduced 15.2% in globus pallidus, 8.8% in putamen and 9.0% in thalamus, respectively). Between neonatal bilirubin encephalopathy and control newborns, the values of MK, AK, RK, and MD more markedly varied in the globus pallidus than in the putamen and thalamus. However, FA more obviously changed in the thalamus than in the globus pallidus and putamen.Conclusions: DKI detects significant microstructural changes, which are consistent with known patterns of neurological damage in neonatal bilirubin encephalopathy. DKI parametrics can comprehensively evaluate microstructural changes and may serve as an in vivo marker for neonatal bilirubin encephalopathy.

No abstract